Doshi Dipal (CIK 0001613084)

Latest company ownership

Shares held
415,664
Last filed at
Sep 4, 2025
Confidence Score
49.8
2025Q4
Confidence Score History
2022Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 2, 2025 Sep 4, 2025 Entrada Therapeutics, Inc. CEO Sell 46.3 -8,723 -2.06% ✗ $47.4K
Mar 1, 2025 Mar 4, 2025 Entrada Therapeutics, Inc. CEO Sell 95.0 +98,634 30.28% ✗ $205.1K
Sep 3, 2024 Sep 5, 2024 Entrada Therapeutics, Inc. CEO Sell 42.5 -8,722 -2.61% ✗ $136.4K
Jul 12, 2024 Jul 16, 2024 Entrada Therapeutics, Inc. CEO Sell 51.3 -1,900 -0.56% ✓ $33.9K
Jun 13, 2024 Jun 14, 2024 Entrada Therapeutics, Inc. CEO Sell 52.5 -1,000 -0.30% ✓ $16.2K
May 16, 2024 May 20, 2024 Entrada Therapeutics, Inc. CEO Sell 51.3 -3,000 -0.88% ✓ $45.1K
Mar 1, 2024 Mar 5, 2024 Entrada Therapeutics, Inc. CEO Sell 95.0 +97,096 39.91% ✗ $95.1K
Feb 15, 2024 Feb 20, 2024 Entrada Therapeutics, Inc. CEO Sell 52.5 -1,000 -0.41% ✓ $15K
Jan 16, 2024 Jan 18, 2024 Entrada Therapeutics, Inc. CEO Sell 52.5 -1,000 -0.41% ✓ $16K
Dec 20, 2023 Dec 22, 2023 Entrada Therapeutics, Inc. CEO Sell 52.5 -1,000 -0.41% ✓ $15K
Nov 13, 2023 Nov 13, 2023 Entrada Therapeutics, Inc. CEO Sell 52.5 -1,000 -0.40% ✓ $16.2K
Oct 17, 2023 Oct 19, 2023 Entrada Therapeutics, Inc. CEO Sell 52.5 -1,000 -0.40% ✓ $15K
Sep 13, 2023 Sep 15, 2023 Entrada Therapeutics, Inc. CEO Sell 52.5 -1,000 -0.40% ✓ $15K
Sep 1, 2023 Sep 6, 2023 Entrada Therapeutics, Inc. CEO Sell 91.3 +48,210 23.98% ✗ $20.8K
Aug 14, 2023 Aug 16, 2023 Entrada Therapeutics, Inc. CEO Sell 52.5 -1,000 -0.49% ✓ $15.7K
Apr 27, 2023 May 1, 2023 Entrada Therapeutics, Inc. CEO Sell 51.3 -2,000 -0.98% ✓ $27.4K
Apr 17, 2023 Apr 19, 2023 Entrada Therapeutics, Inc. CEO Sell 48.8 -2,092 -1.01% ✓ $37.7K
Mar 27, 2023 Mar 29, 2023 Entrada Therapeutics, Inc. CEO Sell 51.3 -2,000 -0.78% ✓ $29.4K
Mar 1, 2023 Mar 3, 2023 Entrada Therapeutics, Inc. CEO Sell 91.3 +95,976 59.30% ✗ $38.5K
Feb 28, 2023 Mar 2, 2023 Entrada Therapeutics, Inc. CEO Sell 48.8 -2,000 -1.22% ✓ $24K
Jan 27, 2023 Jan 30, 2023 Entrada Therapeutics, Inc. CEO Sell 48.8 -2,000 -1.21% ✓ $24K
Jan 9, 2023 Jan 10, 2023 Entrada Therapeutics, Inc. CEO Sell 48.8 -2,410 -1.43% ✓ $36.2K
Dec 27, 2022 Dec 29, 2022 Entrada Therapeutics, Inc. CEO Sell 28.8 -14,590 -7.98% ✓ $219.1K
Nov 28, 2022 Nov 30, 2022 Entrada Therapeutics, Inc. CEO Sell 48.8 -2,000 -1.08% ✓ $27.8K
Oct 25, 2022 Oct 27, 2022 Entrada Therapeutics, Inc. CEO Sell 30.0 -14,061 -7.07% ✓ $292.5K
Oct 20, 2022 Oct 24, 2022 Entrada Therapeutics, Inc. CEO Sell 41.3 -5,939 -2.90% ✓ $110.7K
Sep 26, 2022 Sep 28, 2022 Entrada Therapeutics, Inc. CEO Sell 37.5 -10,587 -4.91% ✓ $161.4K
Sep 21, 2022 Sep 23, 2022 Entrada Therapeutics, Inc. CEO Sell 41.3 -4,425 -2.01% ✓ $66.8K
Sep 15, 2022 Sep 19, 2022 Entrada Therapeutics, Inc. CEO Sell 56.3 -200 -0.09% ✓ $3K
Sep 8, 2022 Sep 12, 2022 Entrada Therapeutics, Inc. CEO Sell 51.3 -1,788 -0.81% ✓ $27K
Aug 29, 2022 Aug 31, 2022 Entrada Therapeutics, Inc. CEO Sell 51.3 -2,000 -0.96% ✓ $25.4K
Jul 27, 2022 Jul 29, 2022 Entrada Therapeutics, Inc. CEO Sell 51.3 -2,000 -0.95% ✓ $24K
Jun 27, 2022 Jun 29, 2022 Entrada Therapeutics, Inc. CEO Sell 48.8 -4,000 -1.86% ✓ $48K